Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Sep 28, 2012

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • going through amenorrhea above 6 months and within 5 years,
• • aged 40 to 60 years,
• • going though postmenopausal symptoms,
• • serum E2 concentration \<30pg/ml,
• • serum FSH concentration \>40IU/L.
• Exclusion Criteria:
• • uterine fibroid diameter≥5cm,
• • history of diabetes or hypertension,
• • history of thromboembolism, severe endometriosis, epilepsy, asthma, hyperprolactinemia,
• • first degree relative had a history of breast cancer,
• • being in severe or unstable condition of somatic diseases,
• • receiving HRT in the past 3 month,
• • drug or alcohol abuse in the past 3 month,
• • endometrial thickness ≥0.5cm after withdrawal bleeding,
• • being allergic to the medicine,
• • participating in other clinical trials within 1 month ago.

Trial Officials